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KinBACKGROUND Unlike most noninvasive imaging modalities, coronary computed tomography angiography can
characterize subtypes of atherosclerotic plaque.
OBJECTIVES The purpose of this study was to investigate the prognostic implications of adverse coronary plaque
characteristics in patients with suspected coronary artery disease.
METHODS In this SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) post hoc analysis, the presence of
adverse plaque (positive remodeling or low attenuation plaque), obstructive disease, and coronary artery calciﬁcation
within 15 coronary segments was assessed on coronary computed tomography angiography of 1,769 patients who were
followed-up for 5 years.
RESULTS Among study participants (mean age 58  10 years; 56% male), 608 (34%) patients had 1 or more adverse
plaque features. Coronary heart disease death or nonfatal myocardial infarction was 3 times more frequent in patients
with adverse plaque (n ¼ 25 of 608 [4.1%] vs. n ¼ 16 of 1,161 [1.4%]; p < 0.001; hazard ratio [HR]: 3.01; 95% conﬁdence
interval (CI): 1.61 to 5.63; p ¼ 0.001) and was twice as frequent in those with obstructive disease (n ¼ 22 of 452 [4.9%]
vs. n ¼ 16 of 671 [2.4%]; p ¼ 0.024; HR: 1.99; 95% CI: 1.05 to 3.79; p ¼ 0.036). Patients with both obstructive disease
and adverse plaque had the highest event rate, with a 10-fold increase in coronary heart disease death or nonfatal
myocardial infarction compared with patients with normal coronary arteries (HR: 11.50; 95% CI: 3.39 to 39.04;
p < 0.001). However, these associations were not independent of coronary artery calcium score, a surrogate measure of
coronary plaque burden.
CONCLUSIONS Adverse coronary plaque characteristics and overall calciﬁed plaque burden confer an increased risk
of coronary heart disease death or nonfatal myocardial infarction. (Scottish COmputed Tomography of the HEART
Trial [SCOT-HEART]; NCT01149590) (J Am Coll Cardiol 2019;73:291–301) © 2019 The Authors. Published by Elsevier
on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).T he investigation of patients with suspectedcoronary artery disease has previouslyfocused on functional assessments that
attempt to identify the presence of myocardial
ischemia as a downstream surrogate marker of prox-
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292Pathological studies in patients with
myocardial infarction have identiﬁed an
association between plaque rupture and
adverse plaque characteristics that includes
positive remodeling, a large necrotic core,
microcalciﬁcation, and a thin ﬁbrous cap (1).
Correlates of these features have been
described for noninvasive imaging with
coronary CTA and include the presence of
positive remodeling, low attenuation plaque,spotty calciﬁcation, and the “napkin ring” sign (2).
These plaque characteristics are associated with an
increased risk of subsequent acute coronary syn-
dromes (2–4). Recent data have suggested that posi-
tive remodeling and low attenuation plaque in
particular provide the most useful prognostic infor-
mation (2,5), although it remains unclear whether this
is of incremental value to traditional cardiovascular
risk factors or coronary plaque burden.SEE PAGE 302In the SCOT-HEART (Scottish COmputed Tomog-
raphy of the HEART) prospective, multicenter, ran-
domized controlled trial of patients with stable chest
pain, the addition of coronary CTA to routine care led
to improved diagnostic certainty and patient care that
ultimately reduced the rate of coronary heart disease
death or nonfatal myocardial infarction (6–8). These
beneﬁts were largely attributable to subsequent
changes in patient management and treatment,
which had been guided by the presence of obstructive
or nonobstructive coronary artery disease as deter-
mined by coronary CTA. However, it may be that
further risk stratiﬁcation and targeted intensiﬁcation
of therapy in patients with adverse plaque charac-
teristics could achieve additional beneﬁts that go
beyond the presence of obstructive or nonobstructive
coronary artery disease.
In this secondary analysis of the SCOT-HEART trial,
we aimed to determine the extent of adverseby The Chief Scientist Ofﬁce of the Scottish Government Health
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received December 27, 2017; revised manuscript received Octobcoronary artery plaque characteristics on coronary
CTA and their association with subsequent clinical
outcomes. If conﬁrmed, the identiﬁcation of these
coronary artery plaque characteristics may help risk
stratiﬁcation and guide the intensity of therapy.
METHODS
STUDY DESIGN. The SCOT-HEART trial was a multi-
center randomized controlled trial of coronary CTA in
outpatients with suspected angina pectoris due to
coronary artery disease (9). The primary results have
been reported previously (6–8). This paper presents a
secondary post hoc analysis of the SCOT-HEART
study.
PARTICIPANTS. In brief, 4,146 patients who atten-
ded the cardiology outpatient clinic were randomized
to standard care alone or standard care plus coronary
CTA, and were followed up for symptoms, manage-
ment, and outcomes. Of the 2,073 participants who
were randomized to the intervention arm, 1,778
underwent coronary CTA. Coronary CTA and non-
contrast imaging for calcium scoring was performed
as described previously (7). Cardiovascular risk was
assessed using the ASSIGN (ASsessing cardiovascular
risk using Scottish Intercollegiate Guideline Network
guidelines) score. This score has been validated for
the Scottish population and, in addition to traditional
cardiovascular risk factors, incorporates social depri-
vation and family history of cardiovascular disease
(10).
ASSESSMENT OF COMPUTED TOMOGRAPHY IMAGES.
Coronary artery calcium score was assessed on non-
contrast computed tomography (CT) using the Agat-
ston scoring method as previously described (11).
Coronary artery calcium scores were classiﬁed into 4
categories (0, 1 to 99, 100 to 399, and $400 Agatston
units [AU]).
On coronary CTA images, per-segment assessment
of atherosclerotic plaque was performed using aand Social Care Directorates (CZH/4/588), with sup-
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ovision of 320-multidetector CT for NHS Lothian and
urgh) is supported by the National Health Service
d. The Clinical Research Facility Glasgow and Clinical
ndNewby (CH/09/002, RE/13/3/30183) are supported
he Chief Scientist Ofﬁce of the Scottish Government
E Healthcare. Dr. Dweck is supported by the British
earch Award 2015 (15/JTA). Dr. Roditi has received
produce contrast media. Drs. Roditi, van Beek, and
s. Dr. van Beek is supported by the Scottish Imaging
me Trust Senior Investigator Award (WT103782AIA).
e contents of this paper to disclose.
er 15, 2018, accepted October 16, 2018.
FIGURE 1 Coronary Plaque Characteristics Identiﬁed on Computed Tomography
Coronary Angiography
Coronary atherosclerotic plaque features detected using computed tomography coronary
angiography including (A) positive remodeling, (B) low-attenuation plaque, (C) spotty
calciﬁcation, and (D) the “napkin ring” sign. Positive remodeling (A) was deﬁned as an
outer vessel diameter (long dashed line) that was 10% greater than the mean diameter
of the segments immediately proximal (short dashed line) and distal to the plaque.
Low-attenuation plaque (B) was deﬁned as a focal central area of plaque with an
attenuation density of <30 Hounsﬁeld Units (yellow arrow). Spotty calciﬁcation (C) was
deﬁned as focal calciﬁcation within the coronary artery wall that measured <3 mm in
maximum diameter (yellow arrow). The “napkin ring” sign (D) was deﬁned as a central
area of low-attenuation plaque with a peripheral rim of high attenuation (yellow arrow).
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29315-segment model by 6 trained observers, with com-
plex cases classiﬁed by consensus (12). Normal coro-
nary arteries were deﬁned by the absence of
obstructive or nonobstructive atherosclerotic plaque.
Nonobstructive coronary artery disease was deﬁned
by the presence of atherosclerotic plaque occupying
a cross-sectional area stenosis #70%. Obstructive
coronary artery disease was deﬁned as a stenosis
>70% in 1 or more major epicardial vessel or >50% in
the left main stem. Observer agreement for the
identiﬁcation of coronary artery disease on coronary
CTA and coronary artery calcium score in the SCOT-
HEART study has previously been shown to be
excellent (13).
For each segment, the presence or absence of 4
coronary artery plaque characteristics was assessed
(Figure 1): positive remodeling, low attenuation pla-
que, spotty calciﬁcation, and the “napkin ring” sign.
Positive remodeling was deﬁned as an outer vessel
diameter that was 10% greater than the mean of the
diameter of the segments immediately proximal and
distal to the plaque (3). Low-attenuation plaque was
deﬁned as a focal central area of plaque with an
attenuation density of <30 Hounsﬁeld Units (14).
Spotty calciﬁcation was deﬁned as focal calciﬁcation
within the coronary artery wall <3 mm in maximum
diameter (3). The “napkin ring” sign was deﬁned, as
previously described, as a central area of low-
attenuation plaque that had a peripheral rim of high
attenuation (15). Observer agreement for the assess-
ment of coronary artery plaque characteristics has
overall been shown to be fair (16).
An individual adverse plaque was deﬁned as one
with positive remodeling or low-attenuation plaque,
as described previously by Motoyama et al. (3). Pa-
tients with 1 or more adverse plaques were deﬁned as
having adverse plaque.
CLINICAL MANAGEMENT AND OUTCOMES. Outcome
information including invasive coronary angiography
and coronary revascularization (percutaneous coro-
nary intervention or coronary artery bypass graft
surgery) was obtained from the electronic Data
Research and Innovation Service of the National
Health Service (NHS) Scotland and, where appro-
priate, conﬁrmed by review of the patient health re-
cords. Categorization of outcomes was performed
blinded to the coronary CTA or other study data. The
primary clinical endpoint for this substudy was the
occurrence of coronary heart disease death or
nonfatal myocardial infarction. Outcome data were
updated in March 2018 (6).
STATISTICAL ANALYSIS. Statistical analysis was
performed using R version 3.5.0 (R Foundation forStatistical Computing, Vienna, Austria). Normally
distributed quantitative variables are presented with
mean  SD. Non-normally distributed data are pre-
sented with median and interquartile range (IQR).
Statistical signiﬁcance was assessed using Pearson’s
chi-square test, Fisher exact test, Student’s t-test,
Mann-Whitney U test, Kruskal-Wallis test, or analysis
of variance as appropriate. Outcome data investi-
gating whether the presence of adverse plaque char-
acteristics predicted coronary heart disease death or
nonfatal myocardial infarction in patients with non-
obstructive disease were analyzed using Cox propor-
tional hazards regression and presented graphically
using cumulative incidence plots. A time-to-event
analysis was performed using coronary heart disease
death or nonfatal myocardial infarction as the
endpoint, with the primary independent variable
TABLE 1 Characteristics of Study Participants
All Participants
(N ¼ 1,769)
Participants Without
Adverse Plaque
(n ¼ 1,161)
Participants With
Adverse Plaque
(n ¼ 608) p Value
Male 997 (56) 545 (47) 452 (74) <0.001
Age, yrs 57.6  9.5 55.9  9.8 60.8  7.8 <0.001
Body mass index, kg/m2 29.6  5.5 30.0  5.8 28.8  4.8 <0.001
Atrial ﬁbrillation 34 (1.9) 20 (1.7) 14 (2.3) 0.399
Smoking status <0.001
Current smoker 330 (19) 208 (18) 122 (20)
Ex-smoker 593 (34) 357 (31) 236 (39)
Nonsmoker 845 (48) 595 (51) 250 (41)
Hypertension 608 (35) 373 (32) 235 (39) 0.005
Diabetes 196 (11) 128 (11) 68 (11) 0.919
Family history of CHD 765 (43) 507 (44) 258 (42) 0.552
Previous CHD 178 (10) 75 (6.5) 103 (17) <0.001
Previous PAD 31 (1.8) 19 (1.6) 12 (2) 0.608
Anginal symptoms <0.001
Typical angina 654 (37) 347 (30) 307 (51)
Atypical angina 432 (24) 293 (25) 139 (23)
Nonanginal 683 (39) 521 (45) 162 (27)
ASSIGN 17.9  11.0 16.1  10.9 21.4  10.6 <0.001
Coronary artery calcium
score (Agatston units)
21 [0–230] 0 [0–34] 281 [89–775] <0.001
Values are n (%), mean  SD, or median [interquartile range]. Values in bold indicate statistical signiﬁcance.
ASSIGN ¼ ASsessing cardiovascular risk using Scottish Intercollegiate Guidelines Network guidelines;
CHD ¼ coronary heart disease; PAD ¼ peripheral arterial disease.
TABLE 2 Frequency of Plaque Characteristics in Each of the 15 Coronary Artery Segments
Adverse
Plaque*
Positive
Remodeling
Low-Attenuation
Plaque
Spotty
Calciﬁcation
Napkin
Ring Sign
Left main stem 60 (3.4) 59 (3.3) 12 (0.7) 13 (0.7) 5 (0.3)
Prox LAD 388 (21.9) 385 (21.8) 78 (4.4) 117 (6.6) 33 (1.9)
Mid LAD 234 (13.2) 224 (12.7) 50 (2.8) 84 (4.7) 13 (0.7)
Dist LAD 21 (1.2) 19 (1.1) 5 (0.3) 14 (0.8) 1 (0.1)
D1 19 (1.1) 19 (1.1) 1 (0.1) 20 (1.1) 1 (0.1)
D2 5 (0.3) 5 (0.3) 0 (0.0) 8 (0.5) 0 (0.0)
Prox Cx 109 (6.2) 106 (6.0) 18 (1.0) 39 (2.2) 6 (0.3)
OM1 27 (1.5) 26 (1.5) 4 (0.2) 13 (0.7) 1 (0.1)
AV Cx 11 (0.6) 11 (0.6) 1 (0.1) 4 (0.2) 1 (0.1)
OM 2 1 (0.1) 1 (0.1) 0 (0.0) 2 (0.1) 0 (0.0)
Mid dist Cx 5 (0.3) 5 (0.3) 0 (0.0) 1 (0.1) 0 (0.0)
Prox RCA 116 (6.6) 112 (6.3) 20 (1.1) 56 (3.2) 6 (0.3)
Mid RCA 132 (7.5) 130 (7.3) 19 (1.1) 63 (3.6) 10 (0.6)
Distal RCA 51 (2.9) 51 (2.9) 4 (0.2) 25 (1.4) 1 (0.1)
RCA/CX PD 10 (0.6) 10 (0.6) 1 (0.1) 13 (0.7) 0 (0.0)
Per-vessel analysis†
LAD 527 (29.8) 517 (29.2) 129 (7.3) 203 (11.5) 52 (2.9)
LCX 139 (7.9) 137 (7.7) 22 (1.2) 52 (2.9) 8 (0.5)
RCA 222 (12.5) 219 (12.4) 41 (2.3) 112 (6.3) 16 (0.9)
Values are n (%). *Positive remodeling or low-attenuation plaque. †1 or more plaque features per-vessel.
AV ¼ atrioventricular; Cx ¼ circumﬂex; D1 ¼ ﬁrst diagonal; D2 ¼ second diagonal; LAD ¼ left anterior
descending; LM ¼ left main; OM1 ¼ obtuse marginal; PD ¼ posterior descending; Prox ¼ proximal; RCA ¼ right
coronary artery.
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294being the presence or absence of adverse plaque on
CT. Deaths not classiﬁed as coronary heart disease
deaths were censored for both the Cox regression
analysis and the cumulative incidence plots. Hazard
ratios (HRs) and 95% conﬁdence intervals (CIs)
are presented. Coronary artery calcium score and
cardiovascular risk score were log transformed for
analysis (log base 2 of 1 plus the parameter). The
variables included in the univariable and multivari-
able analysis are shown in the relevant tables. Vari-
ables were included in multivariable analysis if they
were statistically signiﬁcant on univariable analysis.
The assumption of proportional hazards was checked
using SPSS. A statistically signiﬁcant difference was
deﬁned as a 2-sided p value <0.05.
RESULTS
Of the 1,778 individuals who underwent a coronary
CTA, 1,769 participants had images that were available
and of suitable quality for analysis (Online Figure 1).
Patients had a mean age of 58  10 years, and 56%
were male with a range of cardiovascular risk factors
and symptoms (Table 1). Of these patients, 37%
(n ¼ 646) had normal coronary arteries, 38% (n ¼ 671)
had nonobstructive coronary artery disease, and 26%
(n ¼ 452) had obstructive coronary artery disease.
Coronary heart disease death or nonfatal myocardial
infarction occurred in 41 patients (2.3%) over a median
of 4.7 years of follow-up (IQR: 4.0 to 5.7 years).
PLAQUE CHARACTERISTICS. Coronary CTA charac-
teristics of atherosclerotic plaque were assessed in
26,535 segments in 1,769 patients. This demonstrated
positive remodeling in 1,163 segments (4.4%), low
attenuation plaque in 213 segments (0.8%), spotty
calciﬁcation in 472 segments (1.8%), and the napkin
ring sign in 78 segments (0.3%). All plaque charac-
teristics were more common in the proximal coronary
artery segments, in particular, the proximal left
anterior descending coronary artery (Table 2, Online
Tables 1 to 4).
Adverse plaques were present in 608 (34%) pa-
tients. Patients with adverse plaques were older, had
a higher body mass index, and were more likely to be
male. They were also more likely to have a previous
history of coronary heart disease or hypertension, to
be a smoker, or to have typical angina (Table 1, Online
Table 5). Patients with adverse plaques had a higher
cardiovascular risk score and higher calcium score.
Coronary heart disease death or nonfatal myocardial
infarction was 3 times more frequent in patients with
adverse plaque compared to those without (n ¼ 25 of
608 [4.1%] vs. n ¼ 16 of 1,161 [1.4%]; p < 0.001; HR:
3.01; 95% CI: 1.61 to 5.63; p ¼ 0.001) (Figure 2). Most
FIGURE 2 Coronary Heart Disease Death or Nonfatal Myocardial Infarction Across the Total Cohort in Patients With and Without
Adverse Plaque
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The effect of the presence of 1 or more adverse plaques (deﬁned by the presence of low attenuation or positive remodeling) on subsequent
coronary heart disease (CHD) death or nonfatal myocardial infarction (MI). Cumulative incidence plot for patients with and without adverse
plaque features.
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295events occurred in patients with adverse plaques in
the proximal segments rather than the mid and distal
segments (n ¼ 23 of 489 [4.7%] vs. n ¼ 2 of 119 [1.7%];
p ¼ 0.197). Adverse plaque features appeared to have
a greater prognostic value in women and those under
the age of 60 years, with a body mass index
>30 kg/m2 or with a lower cardiovascular risk score,
but these differences were not statistically signiﬁcant
(Online Table 6). The presence of 1 or more segments
of spotty calciﬁcation or the napkin ring sign was not
associated with a difference in coronary heart disease
death or nonfatal myocardial infarction on per-
patient assessment (Online Tables 3 and 7).
CORONARY ARTERY STENOSIS. Patients with
obstructive coronary artery disease were twice as
likely to experience coronary heart disease death or
nonfatal myocardial infarction (n ¼ 22 of 452 [4.9%])
than patients with nonobstructive disease (n ¼ 16 of
671 [2.4%]; chi-square p ¼ 0.024; HR: 1.99; 95% CI:
1.05 to 3.79; p ¼ 0.036). Patients with obstructive
coronary artery disease were also more likely to
undergo coronary revascularization (n ¼ 215 of
452 [48%] vs. n ¼ 35 of 671 [5%]; p < 0.001) and beprescribed preventative medications at 6 weeks
(n ¼ 427 of 452 [95%] vs. n ¼ 538 of 671 [80%];
p < 0.001) than patients with nonobstructive disease.
Adverse plaques were observed in 40% of patients
with nonobstructive disease (n ¼ 268 of 671) and
three-quarters of patients with obstructive coronary
artery disease (n ¼ 340 of 452). Patients with both
obstructive disease and adverse plaque had the worst
outcome during follow-up (Figure 3). Although the
presence of adverse plaque is suggestive of a worse
prognosis at 2 years in patients with nonobstructive
disease, at 5 years the outcomes of patients with
nonobstructive disease and obstructive disease
without adverse plaque were similar (Figure 3).
Indeed, compared with patients with normal coro-
nary arteries, patients with obstructive disease and
adverse plaque had a >10-fold increase in the rate of
coronary heart disease death or nonfatal myocardial
infarction at 5 years (Table 3).
CORONARY ARTERY CALCIUM SCORE. Patients with
a coronary artery calcium score $1,000 AU had a
13-fold increase in coronary heart disease death or
nonfatal myocardial infarction compared with
FIGURE 3 Coronary Heart Disease Death and Nonfatal Myocardial Infarction in Patients With Different Stenosis Severity and Coronary
Artery Plaque Characteristics
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Cumulative incidence plot for coronary heart disease death and nonfatal myocardial infarction in patients (top) with normal coronary arteries,
nonobstructive disease, and obstructive disease and in (bottom) normal coronary arteries, nonobstructive disease with and without adverse
plaque characteristics, and obstructive disease with and without adverse plaque features. AP ¼ adverse plaque; other abbreviations as
in Figure 2.
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TABLE 3 Univariable and Multivariable Analysis for Coronary Heart Disease Death or
Nonfatal Myocardial Infarction Compared With Patients With Normal Coronary Arteries
Univariable
Analysis p Value
Multivariate
Analysis* p Value
Nonobstructive disease
without adverse
plaque†
4.95 (1.34–18.29) 0.016 2.79 (0.64–12.18) 0.172
Nonobstructive disease
with adverse
plaque†
5.81 (1.50–22.46) 0.011 2.67 (0.53–13.43) 0.234
Obstructive disease
without adverse
plaque†
7.73 (1.73–34.54) 0.007 3.20 (0.52–19.61) 0.208
Obstructive disease
with adverse
plaque†
11.50 (3.39–39.04) <0.001 4.10 (0.76–22.0) 0.100
Coronary artery calcium
score‡
1.23 (1.13–1.35) <0.001 1.12 (0.98–1.28) 0.107
Cardiovascular risk
score§
1.65 (1.13–2.41) 0.01 1.10 (0.71–1.70) 0.673
Values are hazard ratio (95% conﬁdence interval). Values in bold indicate statistical signiﬁcance. *Log rank
statistic 27.29, p < 0.001; Harrell’s C-statistic 0.728 (standard error ¼ 0.046). †Adverse plaque deﬁned as the
presence of positive remodeling or low-attenuation plaque. ‡Per doubling of coronary artery calcium score.
§ASSIGN score, per doubling of cardiovascular risk score.
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297patients without coronary artery calciﬁcation. There
was a clear gradation of risk, with calciﬁcation asso-
ciated with increasing risk (Figure 4). Patients with
obstructive coronary artery disease had an 8-fold
higher coronary artery calcium score than patients
with nonobstructive coronary artery disease (435 AU
[IQR: 138 to 1,127 AU] vs. 54 AU [IQR: 12 to 190 AU];
p < 0.001). In multivariable analysis, the presence of
both adverse plaque and obstructive plaque were
dependent on coronary artery calcium score as a
predictor of coronary heart disease death or nonfatal
myocardial infarction (Table 4, Online Table 8).
There was no difference in the risk of events in
patients with or without adverse plaque who had a
CACS >100 AU. For patients with a CACS <100 AU,
those with adverse plaque were at an increased risk of
coronary heart disease death or nonfatal myocardial
infarction compared with patients without adverse
plaque (HR: 3.38; 95% CI: 1.13 to 10.08; p ¼ 0.03).
DISCUSSION
In a large, multicenter, prospective study of coronary
CTA, we demonstrated that adverse coronary plaque
characteristics are associated with a tripling of the
risk of coronary heart disease death or nonfatal
myocardial infarction. The presence of obstructive
disease was also a major predictor of risk, with the
combination of adverse plaque with obstructive dis-
ease appearing to confer the greatest risk (Central
Illustration). At 5 years, the risk of coronary heart
disease death or nonfatal myocardial infarction was
similar in patients with obstructive disease without
adverse plaque and nonobstructive disease with or
without adverse plaque. However, overall, the only
independent predictor of risk was the coronary artery
calcium score, a surrogate measure of overall plaque
burden. These results suggest that although plaque
composition and its hemodynamic consequences are
associated with future myocardial infarction, the
predominant factor governing patient outcomes is
the burden of coronary atherosclerosis.
Adverse coronary plaque is associated with subse-
quent cardiovascular events in patients with stable
coronary artery disease (2,4,5,17). In keeping with
previous work (2,3,17–19), we found that the plaque
characteristics that were the most helpful in predict-
ing future coronary events were positive remodeling
and low-attenuation plaque. These CT characteristics
are markers of pathological vulnerability (20), and are
potential culprit lesions for subsequent acute coro-
nary events. Motoyama et al. (2) identiﬁed that the
presence of adverse plaque was predictive of acute
coronary syndrome at 4 years in a study of 3,158patients with 88 events (2.8%). In the PROMISE
(Prospective Multicentre Imaging Study for Evalua-
tion of Chest Pain) trial, adverse plaques were present
in 15% of patients and were associated with an
increased risk of the combined endpoint of death,
myocardial infarction, or unstable angina (21). How-
ever, overall adverse plaques have a low positive
predictive value for the identiﬁcation of subsequent
coronary events. This is in keeping with the known
theory of continuous plaque remodeling, where
adverse plaques may stabilize with or without sub-
clinical rupture, rather than cause a clinically
apparent acute coronary syndrome.
Acute myocardial infarction occurs when there is
rupture or erosion of a coronary atherosclerotic plaque
and there is associated thrombus formation causing
vessel occlusion (22). The presence of pre-existing
ﬂow limitation due to obstructive atheroma is not a
prerequisite for this process. Indeed, it should be
remembered that the majority (w80%) of myocardial
infarctions are attributable to nonobstructive coro-
nary plaques on antecedent angiography (23). More-
over, the risk of future myocardial infarction is similar
whether the coronary plaque causes 50% to 85% or
>85% luminal stenosis (24). A nested case-control
study of patients without known coronary artery dis-
ease within the CONFIRM (Coronary CT Angiography
Evaluation for Clinical Outcomes: An International
Multicentre) registry identiﬁed that >65% of patients
who developed acute coronary syndromes had non-
obstructive disease on their baseline coronary CTA
(25). This reﬂects the important nature of the biology
FIGURE 4 Coronary Heart Disease Death or Nonfatal Myocardial Infarction in Patients With Different Severity of Coronary
Artery Calciﬁcation
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298of the atherosclerotic plaque rather than the func-
tional consequence of luminal stenosis (26). For the
prediction of subsequent coronary events, the pres-
ence of atherosclerotic plaque is more important than
the presence of coronary stenoses. Indeed, in our
study, patients with a combination of both obstructive
coronary artery disease and adverse plaque had the
worst outcomes. Moreover, patients with non-
obstructive disease and adverse plaque had similar
outcomes to patients with obstructive disease without
adverse plaque. Thus, our study provides evidenceand Multivariable Analysis for Coronary Heart Disease Death or
nfarction Across the Total Population
Univariable
Analysis p Value
Multivariable
Analysis* p Value
3.01 (1.61–5.63) 0.001 1.18 (0.55–2.52) 0.671
score‡ 1.23 (1.13–1.35) <0.001 1.17 (1.04–1.33) 0.011
rtery disease 3.35 (1.81–6.19) <0.001 1.36 (0.63–2.93) 0.439
re§ 1.65 (1.13–2.41) 0.01 1.14 (0.74–1.75) 0.563
5% conﬁdence interval). Values in bold indicate statistical signiﬁcance. *Log rank
1), Harrell’s C-statistic 0.723 (standard error ¼ 0.046). †Compared with patients
he total population. Adverse plaque deﬁned as the presence of positive remodeling or
er doubling of coronary artery calcium score. §ASSIGN score, per doubling of car-that coronary artery disease should no longer be
deﬁned based on luminal severity, but instead by the
volume and type of disease.
When examined across the cohort as a whole,
adverse plaques did not provide independent prog-
nostic information when CT calcium scoring was
included. CT calcium scoring is a surrogate marker of
plaque burden, and its prognostic utility has been
established in large studies of symptomatic and
asymptomatic patients (27,28). It is likely that pa-
tients with higher plaque burden are more likely to
have adverse plaques and are more likely to have
severe coronary artery stenoses. Few studies have
assessed the clinical implications of this overlap. A
small study of 339 patients with suspected coronary
artery disease found that both adverse plaques and
CT calcium score were independent predictors of
cardiac events at 2 years (29). Clearly, the greater the
burden of disease, the greater the risk of events.
However, for the individual patient, the assessment
of coronary artery calcium alone is not sufﬁcient to
guide management, as the presence and volume of
coronary artery calciﬁcation is not directly related to
the degree of coronary artery stenosis and cannot
CENTRAL ILLUSTRATION Adverse Plaque on Computed Tomography Coronary Angiography Identiﬁes Patients
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299inform on the pathophysiological status of the
atherosclerotic plaque (30). Indeed, in the PROMISE
study, coronary CTA provided better prognostic
discrimination compared to coronary artery calcium
score (31). Intriguingly, we also observed that adverse
plaque was particularly discriminatory in patients
with a low calcium score, reafﬁrming the concept that
calciﬁcation is a healing or protective response to
coronary atherosclerosis and that large areas of
calciﬁcation are associated with plaque stabilization.
It is perhaps not surprising that the identiﬁcation
of plaque characteristics at a single time point by
coronary CTA may not be sufﬁcient to predict future
events in long-term follow-up. Atherosclerotic pla-
que undergoes continuous remodeling driven by avariety of genetic and environmental factors, and we
know that medications, such as statins, alter the
constituents of atherosclerotic plaque (32). Autopsy
studies show that atherosclerosis is present in young
people (33) and nomograms for CT calcium score (28)
and plaque burden (34) are in clinical use. Concerns
have been raised about overmedicating patients with
the routine use of preventative therapies for patients
with nonobstructive disease (35). However, the
event rate in patients with nonobstructive disease in
our study highlights that atherosclerosis is not
“normal.” Similarly, in the PROMISE study, coronary
CTA identiﬁed patients with nonobstructive disease
who were at risk of subsequent events (36). Future
studies should assess whether the identiﬁcation of
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Spe-
ciﬁc characteristics of coronary artery atherosclerotic
plaques are associated with a higher risk of death due
to coronary heart disease or nonfatal myocardial
infarction. This association is related to the severity of
calciﬁcation, a marker of plaque burden.
TRANSLATIONAL OUTLOOK: Prospective studies
should investigate whether more intensive therapy of
stable patients with high-risk coronary plaque char-
acteristics reduces the risk of clinical ischemic events.
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300coronary artery disease per se can guide treatment
changes and improve outcomes for the wider
population.
STUDY LIMITATIONS. First, the relatively low num-
ber of events over 5 years of follow-up limits our
power to assess multiple subgroups. This, in part,
reﬂects our selection of the hard clinical endpoint of
coronary heart disease death or nonfatal myocardial
infarction as well as the low to intermediate risk of
the population recruited in the SCOT-HEART trial.
Second, the SCOT-HEART study was not designed or
powered for this secondary analysis, and our ﬁndings
are exploratory. Third, we used a simple and prag-
matic approach to the identiﬁcation of adverse
plaques that would not greatly add to the time spent
analyzing CT scans. Automated software that can
identify plaque characteristics may further improve
observer variability in the classiﬁcation of adverse
plaques and help standardization. Finally, the trial
did encourage the use of secondary preventative
therapies in patients found to have either obstructive
or nonobstructive disease. This will have inevitably
reduced the number of events as well as reduced our
ability to identify associations between plaque char-
acteristics and clinical events because they will have
been modiﬁed by the initiation of antiplatelet and
statin therapies.
CONCLUSIONS
We have demonstrated that adverse plaque charac-
teristics provide prognostic information out to5 years, but that this is not independent of plaque
burden assessed by coronary artery calcium score.
Patients with obstructive disease and adverse plaques
have the highest event rates throughout follow-up.
This may aid the identiﬁcation of a subgroup of
patients who would beneﬁt from more intensive
medical therapy.
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